Cilengitide Trifluoroacetate: A Potent Integrin Inhibitor for Cancer Research and Development
Discover the critical role of Cilengitide Trifluoroacetate (CAS 199807-35-7) in targeting integrin receptors for advanced cancer therapies and research. Explore its applications and availability from leading Chinese suppliers.
Get a Quote & SampleProduct Core Value
Cilengitide Trifluoroacetate
As a leading supplier in China, we offer Cilengitide Trifluoroacetate (CAS 199807-35-7), a potent and selective integrin inhibitor targeting αvβ3 and αvβ5 receptors. This pharmaceutical intermediate is crucial for blocking cellular interactions and inhibiting angiogenesis, making it a key compound in cancer research and the development of targeted therapies. Its unique properties support its use in various preclinical and clinical studies, positioning it as a vital component for advancing oncology treatments.
- Explore the advanced capabilities of integrin inhibitors in cancer research, utilizing the high purity of our Cilengitide trifluoroacetate.
- Understand the mechanisms of angiogenesis inhibition with this key pharmaceutical intermediate, a vital component in many cancer drug discovery programs.
- Learn about the critical role of αvβ3 and αvβ5 receptor antagonists in developing next-generation cancer therapies.
- Source reliable Cilengitide trifluoroacetate from China, ensuring quality and consistency for your research and development needs.
Advantages Offered
Potent Integrin Inhibition
Cilengitide Trifluoroacetate exhibits high potency and selectivity against αvβ3 and αvβ5 receptors, crucial for a variety of cancer research applications.
Anti-Angiogenic Properties
Its ability to inhibit angiogenesis makes it a valuable tool in studies focused on limiting tumor growth and metastasis, a key aspect of cancer drug discovery.
Pharmaceutical Grade Quality
We ensure high purity of our pharmaceutical intermediates, vital for reproducible and reliable results in scientific research and drug development, supporting effective cancer research.
Key Applications
Cancer Research
Utilized extensively in preclinical and clinical studies for various cancers, investigating mechanisms of tumor growth and response to therapy, a core part of cancer research.
Oncology Drug Development
Serves as a critical building block and research compound for developing novel targeted cancer therapies, contributing to the advancement of oncology drug development.
Angiogenesis Inhibition Studies
A key compound for research into the inhibition of blood vessel formation in tumors, a vital strategy in the fight against cancer, supporting angiogenesis inhibition studies.
Pharmaceutical Intermediate Sourcing
Reliable sourcing of high-quality pharmaceutical intermediates from China for global research institutions and pharmaceutical companies, ensuring a stable supply chain.